Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Stefan 2020 Nat Rev Endocrinol

From Bioblast
Publications in the MiPMap
Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS (2020) Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020:1โ€2 [published online ahead of print, 2020 Apr 23].

ยป PMID: 32327737 Open Access]

Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS (2020) Nat Rev Endocrinol

Abstract: Preliminary data suggest that people with obesity are at increased risk of severe COVID-19. However, as data on metabolic parameters (such as BMI and levels of glucose and insulin) in patients with COVID-19 are scarce, increased reporting is needed to improve our understanding of COVID-19 and the care of affected patients.

โ€ข Bioblast editor: Gnaiger E

Selected quotes

  • A descriptive study of a small sample of 24 (63 % were men) critically ill patients diagnosed with COVID-19 in the Seattle region was among the first to report BMI data (3 patients with a BMI in the normal category, 7 with overweight, 13 with obesity and 1 with missing data). Although the numbers are too small for meaningful statistical analyses, 85 % of the patients with obesity required mechanical ventilation and 62 % of the

patients with obesity died. These proportions are greater than those in the patients without obesity, in which 64 % required mechanical ventilation and 36 % died 4.

  • Among 4,103 patients with COVID-19 at an academic health system in New York City, BMI >40 kg/m2 was the second strongest independent predictor of hospitalization, after old age 7.

Labels: MiParea: Patients  Pathology: Cardiovascular, Diabetes, Infectious, Obesity 

Organism: Human 

Preparation: Intact organism 

Comorbidity, BMI, mitObesity2020, Virus